Develops drugs for metabolic diseases, including cardiovascular disease and diabetes.
Jun 2026Revenue $10.4M/yrExpenses $117M/yr
No trendCash runway ≈ 3.6 years from Jun 2026
Figures by year
When will BioAge Labs be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $10.4M and expenses $117M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $8.99M | $102M | −$92.8M |
| Dec 2024 | $0.00 | $78.2M | −$78.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.